Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.4200
0.00 (0.00%)
Aug 24, 2026, 3:16 PM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 12.36 million as of August 26, 2026. Its market cap has increased by 87.81% in one year.
Market Cap
12.36M
Enterprise Value
12.00M
Revenue
668.79K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.42
ChartMarket Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 12.36M, an increase of 55.15%. That is a compound annual growth rate of 20.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 12.36M | 14.51% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EZZ Life Science Holdings | 24.48M |
| Algorae Pharmaceuticals | 22.28M |
| Patrys | 20.67M |
| Neurotech International | 17.13M |
| Ceryvyn Therapeutics | 15.05M |
| ReNerve | 13.27M |
| Immuron | 12.09M |
| AdAlta | 11.24M |